• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Vaccine. Quantitation of haemagglutinin in H5N1 influenza viruses reveals low haemagglutinin content of vaccine virus NIBRG-14 (H5N1).

Giuseppe

Emeritus
Vaccine. 2008 Oct 4. [Epub ahead of print]

Quantitation of haemagglutinin in H5N1 influenza viruses reveals low haemagglutinin content of vaccine virus NIBRG-14 (H5N1).

Harvey R, Wheeler JX, Wallis CL, Robertson JS, Engelhard OG. - Division of Virology, National Institute for Biological Standards and Control, Blanche Lane, Potters Bar, Hertfordshire EN6 3QG, United Kingdom.

The assessment of potential candidate influenza vaccine viruses includes a number of factors.

Growth properties of the virus and yield of antigen, specifically the haemagglutinin (HA), are of key importance.

The recently developed H5N1 candidate vaccine virus NIBRG-14 (with HA and NA genes derived from the clade 1 virus A/Viet Nam/1194/2004 in an A/Puerto Rico/8/34 background) has been suggested to yield low amounts of antigen.

While investigating the antigen yield of H5N1 vaccine viruses, we found that accurate quantitation of the HA content of some H5N1 viruses was difficult due to the migration characteristics of the proteins on SDS-PAGE gels.

The HA1 and HA2 bands co-migrated with nucleoprotein (NP) and matrix protein (M1) respectively, preventing accurate analysis.

We have developed an accurate way of quantitating HA from these H5N1 viruses by introducing a deglycosylation step to the standard protocol.

Using this method, we showed reproducibly that the low yield of NIBRG-14 is, at least in part, due to a lower than usual content of HA in virus preparations.

This was also found to be the case for the parent wild type A/Viet Nam/1194/2004 virus.

PMID: 18840494 [PubMed - as supplied by publisher
-
-----
 
Back
Top